Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Medical Xpress on MSN3h
Potential single-dose smallpox and mpox vaccine moves forwardVaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback